BRPI0918873A2 - pollissulfatos de ciclodextrina carboxialquilados úteis como medicamentos. - Google Patents

pollissulfatos de ciclodextrina carboxialquilados úteis como medicamentos.

Info

Publication number: BRPI0918873A2
Authority: BR; Brazil
Prior art keywords: pollisulfates; carboxyalkylated; cyclodextrin; medicaments; useful
Prior art date: 2008-09-22

Application number

BRPI0918873A

Other languages

English (en)

Inventor

August Lodewijk Verbruggen

Dirk Elewaut

Original Assignee

Arcarios B V

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-09-22

Filing date

2009-09-22

Publication date

2015-12-01

2009-09-22 Application filed by Arcarios B V filed Critical Arcarios B V

2015-12-01 Publication of BRPI0918873A2 publication Critical patent/BRPI0918873A2/pt

Links

239000003814 drug Substances 0.000 title 1
HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical class O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Hematology (AREA)
Biochemistry (AREA)
Polymers & Plastics (AREA)
Virology (AREA)
Materials Engineering (AREA)
Diabetes (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Rheumatology (AREA)
Immunology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

BRPI0918873A 2008-09-22 2009-09-22 pollissulfatos de ciclodextrina carboxialquilados úteis como medicamentos. BRPI0918873A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP08164818		2008-09-22
PCT/EP2009/062277 WO2010031876A1 (en)	2008-09-22	2009-09-22	Carboxyethylated cyclodextrin polysulfates useful as medicaments

Publications (1)

Publication Number	Publication Date
BRPI0918873A2 true BRPI0918873A2 (pt)	2015-12-01

Family

ID=40342087

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0918873A BRPI0918873A2 (pt)	2008-09-22	2009-09-22	pollissulfatos de ciclodextrina carboxialquilados úteis como medicamentos.

Country Status (9)

Country	Link
US (1)	US8466278B2 (pt)
EP (1)	EP2331581A1 (pt)
JP (1)	JP5508421B2 (pt)
KR (1)	KR20110067130A (pt)
CN (1)	CN102300880B (pt)
BR (1)	BRPI0918873A2 (pt)
CA (1)	CA2738018A1 (pt)
EA (1)	EA018959B1 (pt)
WO (1)	WO2010031876A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2013215237B2 (en) *	2012-01-30	2017-11-23	Baxalta GmbH	Non-anticoagulant sulfated or sulfonated polysaccharides
ITMI20132116A1 (it) *	2013-12-18	2015-06-19	Apharm Srl	Associazione di glicosamminoglicani e ciclodestrine
AU2017256640B2 (en) *	2016-04-29	2020-07-30	Alveron Pharma B.V.	Cyclodextrins as Procoagulants
CN115038723A (zh) *	2019-11-18	2022-09-09	锡德克斯药物公司	烷基化环糊精组合物及其制备和使用方法
CN113528488B (zh) *	2021-08-17	2022-09-27	南昌大学	一种树脂搅拌吸附制备高质量玻璃酸酶粗品的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR900700114A (ko) *	1988-01-19	1990-08-11	모세 쥬다 포크만	성장억제 작용제 및 그 사용법
US5760015A (en) *	1988-01-19	1998-06-02	The Trustees Of The University Of Pennsylvania	Cyclodextrin compounds and methods of making and use thereof
JP2556236B2 (ja)	1991-08-29	1996-11-20	田辺製薬株式会社	β−シクロデキストリン誘導体のポリ硫酸エステル及びその製法
CA2124857A1 (en) *	1991-11-11	1993-05-27	Howard C. Herrmann	Methods of inhibiting restenosis
JP4782334B2 (ja)	1999-08-13	2011-09-28	ナームローゼ・フエンノートチヤツプ・オルガノン	薬物起因性神経筋遮断のための拮抗薬としての化学的キレート化剤の使用
EP1282690B9 (en)	1999-10-06	2005-03-02	Tigenix N.V.	Isolation of precursor cells and their use for tissue repair
FR2811572B1 (fr) *	2000-07-17	2003-04-18	Adir	Utilisation de cyclodextrines polysulfatees pour le traitement de l'arthrose
CA2533124C (en)	2003-08-12	2014-01-28	Tigenix N.V.	Use of cxcl6 chemokine in the prevention or repair of cartilage defects

2009
- 2009-09-22 US US13/120,176 patent/US8466278B2/en not_active Expired - Fee Related
- 2009-09-22 CA CA2738018A patent/CA2738018A1/en not_active Abandoned
- 2009-09-22 JP JP2011527356A patent/JP5508421B2/ja not_active Expired - Fee Related
- 2009-09-22 WO PCT/EP2009/062277 patent/WO2010031876A1/en not_active Ceased
- 2009-09-22 EP EP09783292A patent/EP2331581A1/en not_active Withdrawn
- 2009-09-22 KR KR1020117008751A patent/KR20110067130A/ko not_active Withdrawn
- 2009-09-22 EA EA201170369A patent/EA018959B1/ru not_active IP Right Cessation
- 2009-09-22 CN CN2009801414938A patent/CN102300880B/zh not_active Expired - Fee Related
- 2009-09-22 BR BRPI0918873A patent/BRPI0918873A2/pt not_active IP Right Cessation

Also Published As

Publication number	Publication date
EA201170369A1 (ru)	2011-10-31
KR20110067130A (ko)	2011-06-21
US20110172182A1 (en)	2011-07-14
EA018959B1 (ru)	2013-12-30
CN102300880B (zh)	2013-06-19
CN102300880A (zh)	2011-12-28
JP2012503059A (ja)	2012-02-02
JP5508421B2 (ja)	2014-05-28
WO2010031876A1 (en)	2010-03-25
US8466278B2 (en)	2013-06-18
EP2331581A1 (en)	2011-06-15
CA2738018A1 (en)	2010-03-25

Legal Events

Date	Code	Title	Description
2016-09-13	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 7A ANUIDADE.
2017-01-10	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
BRPI0919295A2 (pt)	2015-12-15	1h-benzimidazol-5-carboxamidas como agentes anti-inflamatórios.
BRPI0906611A2 (pt)	2015-07-14	Produtos implantáveis compreendendo nanopartículas.
BRPI0920428A2 (pt)	2019-09-24	inalador.
NO2021006I1 (no)	2021-02-15	Quofenix, delafloksacin
BRPI0918430A2 (pt)	2015-11-24	4-fenil-1h-pirazóis inseticidas.
BRPI1011965A2 (pt)	2016-04-26	estrutura de entressola.
BRPI0923912A2 (pt)	2016-01-12	aparelho de cateter.
BRPI1007310A2 (pt)	2015-08-25	Compostos inseticidas.
BRPI1008939A2 (pt)	2016-03-15	2-mercaptoquinolina-3-carboxamidas substituídas como moduladores de kncq2/3.
BRPI0922391A2 (pt)	2017-05-30	pneumático.
HRP20150107T1 (xx)	2015-03-13	Derivati dioksabiciklo[3.2.1]oktan-2,3,4-triola
EP2344471A4 (en)	2012-05-30	7-PIPERIDINALKYL-3,4-dihydroquinolone DERIVATIVE
BRPI1016190A2 (pt)	2017-03-28	compostos farmacêuticos.
BRPI0923418A2 (pt)	2017-05-30	pneumático.
BRPI1011460A2 (pt)	2015-08-25	Composição desinfetante.
IT1400534B1 (it)	2013-06-11	Veicolo di piccole dimensioni.
BRPI0917446A2 (pt)	2015-12-22	derivados de acilaminobenzamida.
PT1991529E (pt)	2010-01-06	Arilsulfonamidas substituídas como produtos antivirais
IT1396487B1 (it)	2012-12-14	Convogliatore.
BRPI1013799A2 (pt)	2016-04-12	eletrodos de desfibrilação.
BRPI1016192A2 (pt)	2016-04-19	derivados de soxazol.
DK2442870T3 (da)	2014-06-30	Pyrazinooxazepin-derivater.
BRPI1013966A2 (pt)	2016-08-09	microensaio de esterilidade rápida.
BRPI1011794A2 (pt)	2018-02-27	compartimento.
BRPI0923387A2 (pt)	2016-01-12	pneumático.